Keating Financial Advisory Services’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.4K Buy
73
+11
+18% +$2.89K ﹤0.01% 985
2026
Q1
$16.5K Buy
62
+27
+77% +$7.31K ﹤0.01% 966
2025
Q4
$8.78K Buy
+35
New +$9.3K ﹤0.01% 1134

Other funds holding LH

Keating Financial Advisory Services's LH Position: Q2 2026 in Review

Keating Financial Advisory Services increased its Labcorp (LH) stake by 18% in Q2 2026, buying an estimated $2.89K and bringing the position to 73 shares worth $20.4K. The position accounts for ﹤0.01% of the portfolio, ranked #985.

Keating Financial Advisory Services first reported a position in LH in Q4 2025 and has held it in 3 quarters since. 1,055 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Keating Financial Advisory Services held 73 shares of Labcorp worth $20.4K as of Q2 2026.
  • Keating Financial Advisory Services bought 11 Labcorp shares in Q2 2026, an estimated $2.89K.
  • Labcorp made up ﹤0.01% of Keating Financial Advisory Services's portfolio in Q2 2026, its #985 holding.
  • Keating Financial Advisory Services first reported a position in Labcorp in Q4 2025 and has held it in 3 quarters since.
  • 1,055 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Keating Financial Advisory Services's 13F filing for Q2 2026, filed 11 Aug 2026.